<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00779077</url>
  </required_header>
  <id_info>
    <org_study_id>DPM-OSM-403</org_study_id>
    <nct_id>NCT00779077</nct_id>
  </id_info>
  <brief_title>Cystic Fibrosis (CF) Flow Rates Study</brief_title>
  <official_title>An Open, Observational, Non-Interventional Study of Inspiratory Flow Rates and Volumes in Subjects With Cystic Fibrosis Inhaling Via a Spirometer With the High Resistance RS01 Dry Powder Inhaler Device in Series</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pharmaxis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pharmaxis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We wish to measure the inspiratory flow and volumes generated by the subjects inhaling from a
      spirometer with a high resistance dry powder inhaler in series in subjects with cystic
      fibrosis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>inspiratory flow rates</measure>
    <time_frame>single visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>inspiratory volumes</measure>
    <time_frame>single visit</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>cystic fibrosis</arm_group_label>
    <description>adults and children with cystic fibrosis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        CF 6yrs and above
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CF

          -  FEV1 â‰¥ 30% and &lt; 90% predicted

        Exclusion Criteria:

          -  Be considered &quot;terminally ill&quot; or listed for lung transplantation

          -  Have had a lung transplant

          -  Have had a significant episode of haemoptysis (&gt;60 ml) in the three months prior to
             enrolment

          -  Have had a myocardial infarction in the three months prior to enrolment

          -  Have had a cerebral vascular accident in the three months prior to enrolment

          -  Have had major ocular surgery in the three months prior to enrolment

          -  Have had major abdominal, chest or brain surgery in the three months prior to
             enrolment

          -  Have a known cerebral, aortic or abdominal aneurysm

          -  Be breast feeding or pregnant

          -  Be using beta blockers

          -  Have unstable asthma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2008</study_first_submitted>
  <study_first_submitted_qc>October 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2008</study_first_posted>
  <last_update_submitted>April 22, 2009</last_update_submitted>
  <last_update_submitted_qc>April 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Brett Charlton</name_title>
    <organization>Pharmaxis</organization>
  </responsible_party>
  <keyword>device characteristics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

